A groundbreaking FDA approval offers the first-ever treatment for ultra-rare Thymidine Kinase 2 Deficiency (TK2d). KYGEVVI, a ...

In a historic medical breakthrough, the US Food and Drug Administration (FDA) has approved KYGEVVI—a combination of ...

Scientists uncovered how the amino acid leucine enhances mitochondrial efficiency by preserving crucial proteins that drive ...

A new study led by Swansea University has revealed a new way to potentially treat certain autoimmune diseases by targeting a ...

Tisento Therapeutics today announced that the findings from the company’s interview study in MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes) were published on ...

BackgroundSepsis is a complex clinical syndrome characterized by dysregulated immune responses, systemic inflammation, and multi-organ dysfunction. It ...

Researchers at the University of Cologne have found that a particular dietary amino acid enhances cellular energy, thereby ...

A longevity expert reveals how immune systems begin aging after 35, making people more susceptible to infections and immune-related disorders over time.

Timeline (Amazentis SA), the Swiss longevity biotech company behind Mitopure® (Urolithin A), today announced major scientific milestones reinforcing its position as a leader in clinically researched ...

A new study led by Swansea University has revealed a new way to potentially treat certain autoimmune diseases by targeting a ...

Alzheimer's disease (AD) is the most common cause of dementia, which is a general term for memory loss and other cognitive ...

POTOMAC, MARYLAND / ACCESS Newswire / November 3, 2025 / IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE American:IGC), a clinical-stage biotechnology company leveraging AI to develop i ...